Dow Jones Futures Edge Higher Oil Slips as Trump Signals No Urgency in Iran Nuclear Deal Senators Cruz and Cantwells College Football Intervention Could Disrupt a Thriving Industry Vedanta and MCX Lead Surge in Retail Shareholding in Q4 What It Signals AI Infrastructure and Energy Plays Outperform Nvidia in Recent Market Trends Jeff Bezos Calls for Tax Exemption for Bottom 50 of US Earners Says Doubling His Taxes Wont Help Teachers Pennsylvania IRC Network Strengthens Manufacturing Sector with Targeted Support Initiatives XBIO Q2 2025 Earnings EPS Beat on Lower Net Loss PreRevenue Status Maintains Workiva WK Q1 2026 Earnings EPS Surprises to the Upside Amid Slight Stock Decline Landstar System LSTR Q1 2026 Earnings EPS Beats Estimates Modestly Stock Edges Higher SCL Q1 2026 Earnings EPS Surpasses Estimates by Small Margin Orthofix Medical Inc OFIX Q1 2026 Earnings Significant EPS Beat Drives Stock Rally GREE Q1 2025 Earnings NarrowerThanExpected Loss Drives Stock Surge Boyd Group Services BGSI Edges Higher as Shares Test Resistance Near 114 AH Realty Trust Inc AHRT Edges Higher Amid Steady Trading International Flavors Fragrances IFF Holds Near 75 as Flat Session Suggests Consolidation Janus Henderson Group JHG Holds Steady Near 52 Key Levels and Volume Dynamics John Wiley Sons WLYB Slides 17 as Publishing Sector Faces Headwinds MillionDollar Salaries BillionDollar Stakes The Battle for Top AI Talent Intensifies ATNM Q1 2026 Earnings NarrowerthanExpected Loss Reflects Cost Discipline Amid IomabB Development SnapOn SNA Holds Steady Near Support as Sector Awaits Catalysts SSM Q1 2026 Earnings Minimal Reported Data Amid Operational Challenges PCTTU Q1 2026 Earnings SmallerthanExpected Loss Amid PreRevenue Operations BWFG Q1 2026 Earnings EPS Beats Estimates by 13 Amid Solid Operating Performance GPRK Q1 2026 Earnings Strong EPS Performance Amidst Operational Progress Serve Robotics Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase Stock Declines AEON Biopharma Q4 2025 Earnings Major EPS Miss and No Revenue Weigh on Investor Sentiment CNTA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment